Free Trial

Sumitomo Mitsui Trust Group Inc. Has $49.72 Million Holdings in Markel Group Inc. (NYSE:MKL)

Markel Group logo with Multi-Sector Conglomerates background

Sumitomo Mitsui Trust Group Inc. decreased its stake in shares of Markel Group Inc. (NYSE:MKL - Free Report) by 7.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,805 shares of the insurance provider's stock after selling 2,398 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.22% of Markel Group worth $49,724,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. State Street Corp grew its position in shares of Markel Group by 4.2% in the 3rd quarter. State Street Corp now owns 329,209 shares of the insurance provider's stock worth $516,391,000 after buying an additional 13,372 shares during the last quarter. Geode Capital Management LLC grew its position in Markel Group by 5.2% during the 3rd quarter. Geode Capital Management LLC now owns 209,054 shares of the insurance provider's stock worth $327,131,000 after purchasing an additional 10,254 shares during the last quarter. Jennison Associates LLC grew its position in Markel Group by 9.9% during the 4th quarter. Jennison Associates LLC now owns 78,735 shares of the insurance provider's stock worth $135,915,000 after purchasing an additional 7,102 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in Markel Group by 1.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 55,718 shares of the insurance provider's stock worth $87,398,000 after purchasing an additional 766 shares during the last quarter. Finally, Thompson Siegel & Walmsley LLC grew its position in Markel Group by 0.3% during the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 46,214 shares of the insurance provider's stock worth $72,490,000 after purchasing an additional 133 shares during the last quarter. Institutional investors own 77.12% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on MKL. Royal Bank of Canada boosted their target price on shares of Markel Group from $1,750.00 to $2,025.00 and gave the stock a "sector perform" rating in a research report on Friday, February 7th. StockNews.com cut shares of Markel Group from a "buy" rating to a "hold" rating in a research note on Friday. Finally, TD Cowen cut shares of Markel Group from a "buy" rating to a "hold" rating and decreased their price objective for the company from $1,986.00 to $1,836.00 in a research note on Monday, December 2nd. One research analyst has rated the stock with a sell rating and six have given a hold rating to the stock. According to data from MarketBeat.com, Markel Group currently has a consensus rating of "Hold" and a consensus price target of $1,685.17.

Check Out Our Latest Analysis on MKL

Insider Transactions at Markel Group

In other news, CEO Thomas Sinnickson Gayner bought 100 shares of Markel Group stock in a transaction that occurred on Friday, February 7th. The shares were purchased at an average price of $2,008.01 per share, with a total value of $200,801.00. Following the completion of the acquisition, the chief executive officer now directly owns 48,945 shares in the company, valued at $98,282,049.45. The trade was a 0.20 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.71% of the company's stock.

Markel Group Stock Performance

Shares of MKL traded down $27.90 during trading hours on Friday, hitting $1,869.04. The stock had a trading volume of 66,854 shares, compared to its average volume of 74,985. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.60 and a current ratio of 0.60. The firm has a 50-day moving average price of $1,780.38 and a 200 day moving average price of $1,662.06. Markel Group Inc. has a fifty-two week low of $1,417.65 and a fifty-two week high of $2,063.68. The firm has a market capitalization of $24.04 billion, a price-to-earnings ratio of 9.39 and a beta of 0.78.

Markel Group (NYSE:MKL - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $20.51 earnings per share for the quarter, missing analysts' consensus estimates of $20.66 by ($0.15). Markel Group had a return on equity of 7.55% and a net margin of 16.34%. As a group, research analysts anticipate that Markel Group Inc. will post 97.92 EPS for the current year.

Markel Group Profile

(Free Report)

Markel Group Inc, a diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany. The company offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind.

Recommended Stories

Institutional Ownership by Quarter for Markel Group (NYSE:MKL)

Should You Invest $1,000 in Markel Group Right Now?

Before you consider Markel Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Markel Group wasn't on the list.

While Markel Group currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines